Literature DB >> 17687391

Early penile rehabilitation following radical prostatectomy: Cleveland clinic experience.

R Raina1, G Pahlajani, A Agarwal, C D Zippe.   

Abstract

Erectile dysfunction is one of the most important quality of life issues following radical prostatectomy. The potency rates reported following nerve-sparing technique varies between 40 and 86%, and the time period required for complete recovery of erectile function varies from 6 to 24 months. The literature evidence suggests that lack of natural erections during this period of time produces cavernosal hypoxia. Prolonged periods of cavernosal hypoxia induce fibrosis, which later increases the incidence of venous leak. Recently, there is a growing interest among the physicians to interrupt these events by preventing cavernosal hypoxia during the period of neuropraxia. Initial studies using intracavernosal injection appears to be beneficial. In this article, we reviewed the pathophysiology of cavernosal hypoxia following radical prostatectomy with currently available evidence for the interventions to promote the nerve recovery and regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687391     DOI: 10.1038/sj.ijir.3901573

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  10 in total

1.  Postprostatectomy erectile dysfunction: the role of penile rehabilitation.

Authors:  Brian P Defade; Culley C Carson; Michael J Kennelly
Journal:  Rev Urol       Date:  2011

2.  Manufacturers' data show increasing implanted cylinder sizes and measured corporal lengths in inflatable penile implants.

Authors:  Charles Welliver; Michael Kottwitz; Ardalan E Ahmad; Steven K Wilson; Tobias S Köhler
Journal:  World J Urol       Date:  2015-10-16       Impact factor: 4.226

Review 3.  Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction.

Authors:  Tariq S Hakky; Adam S Baumgarten; Justin Parker; Yin Zheng; Mike Kongnyuy; Daniel Martinez; Rafael E Carrion
Journal:  Curr Urol Rep       Date:  2014-04       Impact factor: 3.092

4.  Efficacy of vacuum erectile devices (VEDs) after radical prostatectomy: the initial Irish experience of a dedicated VED clinic.

Authors:  G J Nason; F McNamara; M Twyford; F O'Kelly; S White; E Dunne; G C Durkan; S K Giri; G P Smyth; R E Power
Journal:  Int J Impot Res       Date:  2016-05-26       Impact factor: 2.896

Review 5.  Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

Authors:  Xiao Wang; Xinghuan Wang; Tao Liu; Qianwen He; Yipeng Wang; Xinhua Zhang
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

Review 6.  Neuroprotective and Nerve Regenerative Approaches for Treatment of Erectile Dysfunction after Cavernous Nerve Injury.

Authors:  Jeffrey D Campbell; Arthur L Burnett
Journal:  Int J Mol Sci       Date:  2017-08-18       Impact factor: 5.923

7.  Synergistic effect of mesenchymal stem cells infected with recombinant adenovirus expressing human BDNF on erectile function in a rat model of cavernous nerve injury.

Authors:  Su Jin Kim; Sae Woong Choi; Kyung Jae Hur; Sang Hoon Park; Young Chul Sung; Y-Shin Ha; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Sae Woong Kim
Journal:  Korean J Urol       Date:  2012-10-19

8.  Tadalafil in the treatment of erectile dysfunction.

Authors:  Robert M Coward; Culley C Carson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

9.  Improvement in sexual function after robot-assisted radical prostatectomy: A rehabilitation program with involvement of a clinical sexologist.

Authors:  Christina Ljunggren; Peter Ströberg
Journal:  Cent European J Urol       Date:  2015-05-04

Review 10.  Does penile rehabilitation have a role in the treatment of erectile dysfunction following radical prostatectomy?

Authors:  Gideon Blecher; Khaled Almekaty; Odunayo Kalejaiye; Suks Minhas
Journal:  F1000Res       Date:  2017-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.